BioSpace News Archive

The report provides trends prevailing in the global wearable EEG devices market and the factors driving market and also the factors that act as hindrances.

Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, today announced that it extended its distribution agreement with its long-term distribution partner, Nipro Medical Corporation (NMC), for a period of three years through May 2024.

Eli Lilly and Company (NYSE: LLY) will host a webcast on Thursday, July 1, 2021 to discuss the company’s diabetes portfolio and its presentations at the American Diabetes Association’s Virtual 81st Scientific Sessions.

Certilytics, Inc., the leading data and predictive analytics partner for some of the nation’s largest and most advanced healthcare organizations, announced it has achieved certification for the 2020 measurement year through the National Committee for Quality Assurance (NCQA) HEDIS Allowable Adjustments Measure Certification Program™.

Although perovskite quantum dots (PQDs) are rising stars among quantum emitters, their inherent instability has limited their development.

TG Therapeutics, Inc., announced data from TG-1701, the Company’s investigational once-daily, oral BTK inhibitor, as a monotherapy and as a triple therapy in combination with ublituximab, the Company’s novel glycoengineered anti-CD20 monoclonal antibody, and UKONIQ®, the Company’s once-daily, inhibitor of PI3K-delta and CK1-epsilon in patients with front line or relapsed/refractory non-Hodgkin’s lymphoma and chronic lymphocytic leukemia.

Autolus Therapeutics plc, a clinical-stage biopharmaceutical company developing next-generation programmed T cell therapies, announced a poster presentation related to AUTO1 in relapsed / refractory indolent B cell lymphomas and included an update of duration of response in r/r adult Acute Lymphoblastic Leukemia patients at the European Hematology Association Virtual Congress 2021.

Forma Therapeutics Holdings, Inc. a clinical-stage biopharmaceutical company focused on rare hematologic diseases and cancers, announced new data from its ongoing Phase 1 trial of etavopivat being presented at the 26th Annual European Hematology Association 2021 Virtual Congress.

ADC Therapeutics SA today announced that shareholders approved all of the resolutions as proposed by the Board of Directors at yesterday’s Annual General Meeting.

Medexus Pharmaceuticals Inc. today announced that it plans to host a conference call at 8:00 AM Eastern Time on Thursday, June 17, 2021 to discuss the Company’s financial results for the fiscal year-ended March 31, 2021.